Kostic V S, Marinkovic Z, Filipovic S, Momcilovic D
Department of Neurology, School of Medicine, Belgrade, Serbia.
Mov Disord. 1993 Apr;8(2):227-9. doi: 10.1002/mds.870080223.
The basal levels of prolactin (PRL) and their changes after i.v. thyrotropin releasing hormone (TRH) administration after bromocriptine (BCT) pretreatment (BCT/TRH test) were monitored in 12 patients with young-onset Parkinson's disease (PD) (before 40 years of age) and 10 patients with older-onset PD (after 40 years of age), as well as in two groups of healthy subjects (10 persons in each), age-matched with older-onset (control A) and young-onset (control B) parkinsonians. The basal PRL levels were normal in both groups of patients. When given after BCT, TRH induced a significantly lower PRL increase in older-onset parkinsonians than in controls. This response was even more blunted in young-onset patients, being significantly more attenuated than in older-onset PD patients.
对12例早发型帕金森病(PD)患者(年龄在40岁之前)、10例晚发型PD患者(年龄在40岁之后)以及两组健康受试者(每组10人,分别与晚发型帕金森病患者(对照组A)和早发型帕金森病患者(对照组B)年龄匹配),监测了溴隐亭(BCT)预处理后静脉注射促甲状腺激素释放激素(TRH)后催乳素(PRL)的基础水平及其变化(BCT/TRH试验)。两组患者的基础PRL水平均正常。BCT给药后给予TRH,晚发型帕金森病患者PRL升高幅度明显低于对照组。早发型患者的这种反应更为迟钝,比晚发型PD患者显著减弱。